by bmi_wpadmin | Sep 23, 2024 | BayMedica, Partners, Product Actualization
A Guide for CPG Brands Leveraging Minor Cannabinoids As the demand for cannabinoid-infused beverages continues to surge, CPG brands and product developers have a unique opportunity to enter this growing market with innovative, compliant, and consumer-focused products....
by bmi_wpadmin | Sep 15, 2022 | BayMedica
If you have been in the cannabis/cannabinoid industry for any amount of time, you may have encountered the term “entourage effect.” So what exactly is the entourage effect? For starters, it has nothing to do with the—somewhat questionable—2000s TV series. Instead, it...
by bmi_wpadmin | Jul 14, 2022 | BayMedica
Jerry P. Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, is interviewed by Shadd Dales of The Dales Report to talk about the recent B2B sales launch of rare cannabinoid D9 THCV (Tetrahydrocannabivarin) into the health and wellness sector. Full...
by bmi_wpadmin | Jun 2, 2022 | BayMedica, Cannabinoids
As everyone in the cannabis and hemp industries knows, supply chain issues can be a major threat to business. The pandemic has unleashed chaos on supply chains across the globe, and the cannabis industry has not been spared. While the COVID-induced supply chain issues...
Recent Comments